• $4.0M
    Market Cap
  • -97.80%
    1-Year Change
  • Drug Manufacturers - Specialty & Generic
    Industry

Earnings Score

N/A
No data found

No data found

Momentum Score

Score: 29
Valuation
KAYS
vs History
vs S&P 500
3-Month Momentum
-40.62%
12-Month Momentum
-50.12%
3-Month Risk Adjusted Momentum
-10.46%
12-Month Risk Adjusted Momentum
-11.03%

True Yield

N/A
No data found

No data found

Financial Health Score

N/A
No data found

No data found